Indapamide and Joint effusion - a phase IV clinical study of FDA data

Summary:

Joint effusion is reported as a side effect among people who take Indapamide (indapamide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Celebrex, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Joint effusion when taking Indapamide. It is created by eHealthMe based on reports of 21,640 people who have side effects when taking Indapamide from the FDA, and is updated regularly.

What is Indapamide?

Indapamide has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 22,152 Indapamide users. Check the latest studies of Indapamide.

What is Joint effusion?

Joint effusion (presence of extra fluid in joint covering) is found to be associated with 872 drugs and 750 conditions by eHealthMe. Check the latest studies of Joint effusion.

On Jul, 16, 2026

21,640 people reported to have side effects when taking Indapamide.
Among them, 33 people (0.15%) have Joint effusion.

Among these 33 people:

How long have people been on Indapamide when they have Joint effusion? *

What is the gender of people who have Joint effusion when taking Indapamide? *

female: 77.78 %
male: 22.22 %

What is the age of people who have Joint effusion when taking Indapamide? *

What are other drugs people take besides Indapamide? *

Celebrex: 13 people, 39.39%
Acetaminophen: 12 people, 36.36%
Hydroxychloroquine Sulfate: 11 people, 33.33%
Methotrexate: 11 people, 33.33%
Actemra: 10 people, 30.30%
Folic Acid: 10 people, 30.30%
Oxycodone: 9 people, 27.27%
Epipen: 8 people, 24.24%
Pantoprazole: 7 people, 21.21%
Tylenol: 7 people, 21.21%

What are other side effects people have besides Joint effusion? *

Joint Pain: 29 people, 87.88%
Blood Pressure Systolic Increased: 23 people, 69.70%
Pain: 22 people, 66.67%
Joint Swelling: 22 people, 66.67%
Weight Increased: 18 people, 54.55%
Oxygen Saturation Decreased: 17 people, 51.52%
Sinusitis (inflammation of sinus): 17 people, 51.52%
Nasopharyngitis (inflammation of the nasopharynx): 17 people, 51.52%
Cough: 16 people, 48.48%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 14 people, 42.42%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 17 people, 51.52%
Joint Pain: 9 people, 27.27%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 6 people, 18.18%
Sinusitis (inflammation of sinus): 3 people, 9.09%
High Blood Cholesterol: 3 people, 9.09%
Cardiac Disorder: 3 people, 9.09%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 9.09%
Bone Density Decreased: 2 people, 6.06%
Paget's Disease (disorder that involves abnormal bone destruction and regrowth, which results in deformity): 1 person, 3.03%
Ill-Defined Disorder: 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Indapamide and have Joint effusion?

- Check whether Joint effusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Indapamide:

Indapamide (22,152 reports)

Joint effusion treatments and more:

Joint effusion (9,947 reports)

Browse all side effects of Indapamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Joint effusion:

Joint effusion (872 drugs)

Browse all the conditions that are associated with Joint effusion:

Joint effusion (750 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on indapamide (the active ingredients of Indapamide) and Indapamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.